Importance: The influence of Tourette syndrome and chronic tic disorders on academic performance has not been objectively quantified. Objective: To investigate the association of Tourette syndrome and chronic tic disorders with objectively measured educational outcomes, adjusting for measured covariates and unmeasured factors shared between siblings and taking common psychiatric comorbidities into account. Design, Setting, and Participants: A population-based birth cohort consisting of all individuals born in Sweden from 1976 to 1998 was followed up until December 2013. Individuals with organic brain disorders, mental retardation, and 2 foreign-born parents were excluded. We further identified families with at least 2 singleton full siblings and families with siblings discordant for Tourette syndrome or chronic tic disorders. Exposures: Previously validated International Classification of Diseases diagnoses of Tourette syndrome or chronic tic disorders in the Swedish National Patient Register. Main Outcomes and Measures: Eligibility to access upper secondary school after compulsory education, finishing upper secondary school, starting a university degree, and finishing a university degree. Results: Of the 2 115 554 individuals in the cohort, 3590 had registered a diagnosis of Tourette syndrome or a chronic tic disorder in specialist care (of whom 2822 [78.6%] were male; median [interquartile] age at first diagnosis, 14.0 [11-18] years). Of 726 198 families with at least 2 singleton full siblings, 2697 included siblings discordant for these disorders. Compared with unexposed individuals, people with Tourette syndrome or chronic tic disorders were significantly less likely to pass all core and additional courses at the end of compulsory school (odds ratios ranging from 0.23 [95% CI, 0.20-0.26] for the handcraft textile/wood course to 0.36 [95% CI, 0.31-0.41] for the English language course) and to access a vocational program (adjusted OR [aOR], 0.31; 95% CI, 0.28-0.34) or academic program (aOR, 0.43; 95% CI, 0.39-0.47) in upper secondary education. Individuals with the disorders were also less likely to finish upper secondary education (aOR, 0.35; 95% CI, 0.32-0.37), start a university degree (aOR, 0.41; 95% CI, 0.37-0.46), and finish a university degree (aOR, 0.39; 95% CI, 0.32-0.48). The results were only marginally attenuated in the fully adjusted sibling comparison models. Exclusion of patients with neuropsychiatric comorbidities, particularly attention-deficit/hyperactivity disorder and pervasive developmental disorders, resulted in attenuated estimates, but patients with Tourette syndrome or chronic tic disorders were still significantly impaired across all outcomes. Conclusions and Relevance: Help-seeking individuals with Tourette syndrome or chronic tic disorders seen in specialist settings experience substantial academic underachievement across all educational levels, spanning from compulsory school to university, even after accounting for multiple confounding factors and psychiatric comorbidities.
Importance: The influence of Tourette syndrome and chronic tic disorders on academic performance has not been objectively quantified. Objective: To investigate the association of Tourette syndrome and chronic tic disorders with objectively measured educational outcomes, adjusting for measured covariates and unmeasured factors shared between siblings and taking common psychiatric comorbidities into account. Design, Setting, and Participants: A population-based birth cohort consisting of all individuals born in Sweden from 1976 to 1998 was followed up until December 2013. Individuals with organic brain disorders, mental retardation, and 2 foreign-born parents were excluded. We further identified families with at least 2 singleton full siblings and families with siblings discordant for Tourette syndrome or chronic tic disorders. Exposures: Previously validated International Classification of Diseases diagnoses of Tourette syndrome or chronic tic disorders in the Swedish National Patient Register. Main Outcomes and Measures: Eligibility to access upper secondary school after compulsory education, finishing upper secondary school, starting a university degree, and finishing a university degree. Results: Of the 2 115 554 individuals in the cohort, 3590 had registered a diagnosis of Tourette syndrome or a chronic tic disorder in specialist care (of whom 2822 [78.6%] were male; median [interquartile] age at first diagnosis, 14.0 [11-18] years). Of 726 198 families with at least 2 singleton full siblings, 2697 included siblings discordant for these disorders. Compared with unexposed individuals, people with Tourette syndrome or chronic tic disorders were significantly less likely to pass all core and additional courses at the end of compulsory school (odds ratios ranging from 0.23 [95% CI, 0.20-0.26] for the handcraft textile/wood course to 0.36 [95% CI, 0.31-0.41] for the English language course) and to access a vocational program (adjusted OR [aOR], 0.31; 95% CI, 0.28-0.34) or academic program (aOR, 0.43; 95% CI, 0.39-0.47) in upper secondary education. Individuals with the disorders were also less likely to finish upper secondary education (aOR, 0.35; 95% CI, 0.32-0.37), start a university degree (aOR, 0.41; 95% CI, 0.37-0.46), and finish a university degree (aOR, 0.39; 95% CI, 0.32-0.48). The results were only marginally attenuated in the fully adjusted sibling comparison models. Exclusion of patients with neuropsychiatric comorbidities, particularly attention-deficit/hyperactivity disorder and pervasive developmental disorders, resulted in attenuated estimates, but patients with Tourette syndrome or chronic tic disorders were still significantly impaired across all outcomes. Conclusions and Relevance: Help-seeking individuals with Tourette syndrome or chronic tic disorders seen in specialist settings experience substantial academic underachievement across all educational levels, spanning from compulsory school to university, even after accounting for multiple confounding factors and psychiatric comorbidities.
Authors: Rebecca Pinto; Benedetta Monzani; James F Leckman; Christian Rück; Eva Serlachius; Paul Lichtenstein; David Mataix-Cols Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2016-02-27 Impact factor: 3.568
Authors: Jonas F Ludvigsson; Eva Andersson; Anders Ekbom; Maria Feychting; Jeong-Lim Kim; Christina Reuterwall; Mona Heurgren; Petra Otterblad Olausson Journal: BMC Public Health Date: 2011-06-09 Impact factor: 3.295
Authors: G Brander; M Rydell; R Kuja-Halkola; L Fernández de la Cruz; P Lichtenstein; E Serlachius; C Rück; C Almqvist; B M D'Onofrio; H Larsson; D Mataix-Cols Journal: Mol Psychiatry Date: 2017-03-28 Impact factor: 15.992
Authors: Nicholas G Shakeshaft; Maciej Trzaskowski; Andrew McMillan; Kaili Rimfeld; Eva Krapohl; Claire M A Haworth; Philip S Dale; Robert Plomin Journal: PLoS One Date: 2013-12-11 Impact factor: 3.240
Authors: Ashley N Nielsen; Caterina Gratton; Jessica A Church; Nico U F Dosenbach; Kevin J Black; Steven E Petersen; Bradley L Schlaggar; Deanna J Greene Journal: Biol Psychiatry Date: 2019-07-02 Impact factor: 13.382
Authors: Alba Vilaplana-Pérez; Anna Sidorchuk; Ana Pérez-Vigil; Gustaf Brander; Kayoko Isoumura; Eva Hesselmark; Laura Sevilla-Cermeño; Unnur A Valdimarsdóttir; Huan Song; Andreas Jangmo; Ralf Kuja-Halkola; Brian M D'Onofrio; Henrik Larsson; Gemma Garcia-Soriano; David Mataix-Cols; Lorena Fernández de la Cruz Journal: JAMA Netw Open Date: 2020-12-01
Authors: A P Heijerman-Holtgrefe; C W J Verdellen; J M T M van de Griendt; L P L Beljaars; K J Kan; D Cath; P J Hoekstra; C Huyser; E M W J Utens Journal: Eur Child Adolesc Psychiatry Date: 2020-05-20 Impact factor: 4.785
Authors: Barbara Coffey; Joseph Jankovic; Daniel O Claassen; Joohi Jimenez-Shahed; Barry J Gertz; Elizabeth A Garofalo; David A Stamler; Maria Wieman; Juha-Matti Savola; Mark Forrest Gordon; Jessica K Alexander; Hadas Barkay; Eran Harary Journal: JAMA Netw Open Date: 2021-10-01
Authors: David Mataix-Cols; Gustaf Brander; Zheng Chang; Henrik Larsson; Brian M D'Onofrio; Paul Lichtenstein; Anna Sidorchuk; Lorena Fernández de la Cruz Journal: Mov Disord Date: 2020-09-24 Impact factor: 10.338
Authors: Alba Vilaplana-Pérez; Ana Pérez-Vigil; Anna Sidorchuk; Gustaf Brander; Kayoko Isomura; Eva Hesselmark; Ralf Kuja-Halkola; Henrik Larsson; David Mataix-Cols; Lorena Fernández de la Cruz Journal: Psychol Med Date: 2020-01-07 Impact factor: 7.723